HomeAI · summaries
Storia in 3 fonti
Aragen Life Sciences files draft papers with Sebi to raise funds through IPO
Aragen Life Sciences has filed its DRHP with Sebi for an IPO comprising a Rs 800 crore fresh issue and an OFS. Proceeds will fund debt repayment, capacity expansion and equipment purchases. The CRDMO reported strong FY24–FY26 growth, with revenue reaching Rs 2,178 crore and profit Rs 258 crore in FY26.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
thehindubusinessline.com
Aragen Life Sciences files draft papers with SEBI; eyes ₹800-cr via fresh issue
Aragen Life Sciences seeks to raise ₹800 crore through an IPO, filing draft papers with SEBI for a fresh issue and equity sale.
- ·
economictimes.indiatimes.com
Aragen Life Sciences files draft papers with Sebi to raise funds through IPO
Aragen Life Sciences has filed its DRHP with Sebi for an IPO comprising a Rs 800 crore fresh issue and an OFS. Proceeds will fund debt repayment, capacity expansion and equipment…
